August 23, 2021 – ZOLL Medical Corporation (Chelmsford, MA), an Asahi Kasei company, and Wallaby Medical Technologies have signed a distribution agreement whereby Wallaby will manage the sales and distribution of ZOLL’s temperature management products in China.
ZOLL will work with Wallaby to further expand the use of the Thermogard XP in China, allowing more patients to benefit from high-quality targeted temperature management (TTM).
The Thermogard XP Intravascular Temperature Management System (IVTM) offers healthcare providers the precision and speed as characterized in high-quality TTM, resulting in clinically demonstrated improvements in neurological outcomes among survivors of cardiac arrest, the company says.
The system includes a family of heat-exchange catheters that enable clinicians to manage core body temperature according to a patient’s specific needs.
The use of IVTM in cardiac arrest patients has not been cleared or approved by the FDA for use in the U.S.